Latest Stories
3 Reasons to Avoid MGM and 1 Stock to Buy Instead
Over the last six months, MGM Resorts’s shares have sunk to $35.20, producing a disappointing 5.3% loss - a stark contrast to the S&P 500’s 10.1% gain. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons to Avoid THO and 1 Stock to Buy Instead
Over the past six months, THOR Industries has been a great trade, beating the S&P 500 by 16.4%. Its stock price has climbed to $114.79, representing a healthy 26.5% increase. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
2 Reasons to Like ARLO and 1 to Stay Skeptical
Over the past six months, Arlo Technologies’s stock price fell to $14.31. Shareholders have lost 11.9% of their capital, which is disappointing considering the S&P 500 has climbed by 10.1%. This may have investors wondering how to approach the situation.
3 Reasons to Sell NWBI and 1 Stock to Buy Instead
Over the last six months, Northwest Bancshares’s shares have sunk to $12.28, producing a disappointing 7.4% loss - a stark contrast to the S&P 500’s 10.1% gain. This may have investors wondering how to approach the situation.
3 Reasons CNXN is Risky and 1 Stock to Buy Instead
Over the past six months, Connection’s shares (currently trading at $58.52) have posted a disappointing 10.3% loss, well below the S&P 500’s 10.1% gain. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
2 Reasons to Like TTEK (and 1 Not So Much)
Tetra Tech has been treading water for the past six months, recording a small loss of 1.5% while holding steady at $37.33. The stock also fell short of the S&P 500’s 10.1% gain during that period.
A Look Back at Analog Semiconductors Stocks’ Q3 Earnings: onsemi (NASDAQ:ON) Vs The Rest Of The Pack
Looking back on analog semiconductors stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including onsemi (NASDAQ:ON) and its peers.
Q3 Therapeutics Earnings: Halozyme Therapeutics (NASDAQ:HALO) Earns Top Marks
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the therapeutics stocks, including Halozyme Therapeutics (NASDAQ:HALO) and its peers.
Apparel and Accessories Stocks Q3 Highlights: Movado (NYSE:MOV)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how apparel and accessories stocks fared in Q3, starting with Movado (NYSE:MOV).
Q3 Rundown: Danaher (NYSE:DHR) Vs Other Research Tools & Consumables Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how research tools & consumables stocks fared in Q3, starting with Danaher (NYSE:DHR).